tradingkey.logo
tradingkey.logo
Search

Alector Inc

ALEC
Add to Watchlist
2.060USD
+0.050+2.49%
Close 07/02, 13:00ETQuotes delayed by 15 min
228.71MMarket Cap
LossP/E TTM

More Details of Alector Inc Company

Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.

Alector Inc Info

Ticker SymbolALEC
Company nameAlector Inc
IPO dateFeb 07, 2019
CEORosenthal (Arnon)
Number of employees238
Security typeOrdinary Share
Fiscal year-endFeb 07
Address131 Oyster Point Blvd., Suite 600
CitySOUTH SAN FRANCISCO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code94080
Phone14152315660
Websitehttps://alector.com
Ticker SymbolALEC
IPO dateFeb 07, 2019
CEORosenthal (Arnon)

Company Executives of Alector Inc

Name
Name/Position
Position
Shareholding
Change
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.63M
-1.55%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
199.39K
+54.48%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
106.20K
+37.23%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
95.41K
+30.08%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
74.91K
+38.31%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
52.76K
+54.39%
Mr. Louis J. (Lou) Lavigne, Jr.
Mr. Louis J. (Lou) Lavigne, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Dr. Elizabeth A. (Betsy) Garofalo, M.D.
Independent Director
Independent Director
--
--
Dr. Errol De Souza, Ph.D.
Dr. Errol De Souza, Ph.D.
Independent Director
Independent Director
--
--
Mr. Giacomo Salvadore, M.D.
Mr. Giacomo Salvadore, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Arnon Rosenthal, Ph.D.
Dr. Arnon Rosenthal, Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
5.63M
-1.55%
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
Dr. Saraswati (Sara) Kenkare-Mitra, Ph.D.
President, Head - Research and Development
President, Head - Research and Development
199.39K
+54.48%
Dr. Richard H. Scheller, Ph.D.
Dr. Richard H. Scheller, Ph.D.
Director
Director
106.20K
+37.23%
Dr. Kristine Yaffe
Dr. Kristine Yaffe
Independent Director
Independent Director
95.41K
+30.08%
Dr. Paula Hammond, Ph.D.
Dr. Paula Hammond, Ph.D.
Independent Director
Independent Director
74.91K
+38.31%
Mr. Mark Altmeyer
Mr. Mark Altmeyer
Independent Director
Independent Director
52.76K
+54.39%

FAQs

Who are the top five shareholders of Alector Inc?

The top five shareholders of Alector Inc are: Dr. Arnon Rosenthal, Ph.D.

How many institutions hold shares of Alector Inc (ALEC)?

As of 2026Q1, 353 institutions hold shares of Alector Inc, with a combined market value of approximately 89.88M, accounting for 80.95% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -32948606.00.